Hybrid flexible ureteroscopy strategy in the management of renal stones - a narrative review.
flexible ureteroscopy
hybrid technique
renal stones
reusable
single-use
Journal
Journal of medicine and life
ISSN: 1844-3117
Titre abrégé: J Med Life
Pays: Romania
ID NLM: 101477617
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
11
03
2022
accepted:
02
05
2022
entrez:
3
10
2022
pubmed:
4
10
2022
medline:
5
10
2022
Statut:
ppublish
Résumé
The introduction of single-use flexible ureteroscopes (suFURSs) in daily practice tends to overcome the main limitations of reusable ureteroscopes (reFURSs), in terms of high acquisition costs, maintenance, breakages and repairing costs, reprocessing and sterilization, as retrograde intrarenal surgery (RIRS) is promoted as first-line treatment of renal stones in most cases. A hybrid strategy implies having both instruments in the armamentarium of endourology and choosing the best strategy for cost-efficiency and protecting expensive reusable instruments in selected high-risk for breakage cases such as large stones of the inferior calyx, a steep infundibulopelvic angle or narrow infundibulum, or abnormal anatomy as in horseshoe and ectopic kidney. In terms of safety and efficiency, data present suFURSs as a safe alternative considering operating time, stone-free, and complication rates. An important aspect is highlighted by several authors about reusable instrument disinfection as various pathogens are still detected after proper sterilization. This comprehensive narrative review aims to analyze available data comparing suFURSs and reFURSs, considering economic, technical, and operative aspects of the two types of instruments, as well as the strategy of adopting a hybrid approach to selecting the most appropriate flexible ureteroscope in each case.
Identifiants
pubmed: 36188640
doi: 10.25122/jml-2022-0110
pii: JMedLife-15-0919
pmc: PMC9514813
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
919-926Informations de copyright
©2022 JOURNAL of MEDICINE and LIFE.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Int Braz J Urol. 2019 Jul-Aug;45(4):658-670
pubmed: 31397987
Curr Opin Urol. 2021 Mar 1;31(2):87-94
pubmed: 33399370
Turk J Urol. 2020 Nov;46(Supp. 1):S40-S45
pubmed: 32877637
World J Urol. 2018 Dec;36(12):2059-2063
pubmed: 29869701
J Endourol. 2016 Mar;30(3):254-6
pubmed: 26542761
J Endourol. 2017 May;31(5):468-475
pubmed: 28287823
J Endourol. 2021 Oct;35(10):1454-1459
pubmed: 33775101
Res Rep Urol. 2017 Jan 27;9:19-25
pubmed: 28203551
Adv Urol. 2018 Feb 4;2018:3068365
pubmed: 29515627
Res Rep Urol. 2021 Feb 10;13:63-71
pubmed: 33604311
Urology. 1987 Mar;29(3):296-300
pubmed: 3824726
J Urol. 2006 Aug;176(2):607-10; discussion 610
pubmed: 16813899
J Med Life. 2021 Jul-Aug;14(4):557-564
pubmed: 34621382
Urology. 2005 Nov;66(5):958-63
pubmed: 16286103
J Endourol. 2017 Oct;31(10):1026-1031
pubmed: 28830223
Am J Infect Control. 2017 Aug 1;45(8):888-895
pubmed: 28625700
Transl Androl Urol. 2019 Sep;8(Suppl 4):S359-S370
pubmed: 31656742
Minerva Urol Nefrol. 2016 Dec;68(6):479-495
pubmed: 27759737
Int J Urol. 2019 Oct;26(10):999-1005
pubmed: 31448473
Curr Urol Rep. 2020 Mar 31;21(5):18
pubmed: 32236700
J Endourol. 2018 Apr;32(4):267-273
pubmed: 29239227
J Urol. 2019 Jun;201(6):1144-1151
pubmed: 30707130
J Urol. 2009 Nov;182(5):2347-51
pubmed: 19758626
Urology. 2013 Apr;81(4):717-22
pubmed: 23465156
Urol Int. 2007;79 Suppl 1:8-15
pubmed: 17726346
Kidney Int. 2013 Jan;83(1):146-52
pubmed: 22992468
Urol Int. 2020;104(5-6):437-444
pubmed: 31466078
Urology. 2014 Jul;84(1):32-5
pubmed: 24703462
J Endourol. 2001 Sep;15(7):681-5
pubmed: 11697396
Int Braz J Urol. 2015 Jul-Aug;41(4):683-9
pubmed: 26401860
Front Surg. 2021 Oct 13;8:691170
pubmed: 34722620
Int Urol Nephrol. 2019 Oct;51(10):1735-1741
pubmed: 31317310
J Urol. 2002 Jul;168(1):5-8
pubmed: 12050480
Cent European J Urol. 2019;72(2):183-184
pubmed: 31482027
J Urol. 2000 Oct;164(4):1164-8
pubmed: 10992358
J Endourol. 2020 Jan;34(1):18-24
pubmed: 31432716
J Endourol. 2021 Jun;35(6):903-907
pubmed: 27981862
Lancet. 2006 Jan 28;367(9507):333-44
pubmed: 16443041
J Urol. 1964 Jan;91:110-4
pubmed: 14106571
World J Urol. 2018 Apr;36(4):529-536
pubmed: 29177820
J Urol. 2017 Mar;197(3 Pt 1):730-735
pubmed: 27693449
Transl Androl Urol. 2021 Jan;10(1):483-493
pubmed: 33532336
Cent European J Urol. 2016;69(3):274-279
pubmed: 27729994
Urolithiasis. 2018 Feb;46(1):47-58
pubmed: 29222575
Curr Opin Urol. 2020 Mar;30(2):113-119
pubmed: 31815748
Urolithiasis. 2020 Jun;48(3):263-270
pubmed: 31372691
Urology. 2002 Nov;60(5):784-8
pubmed: 12429296
Minerva Urol Nefrol. 2016 Dec;68(6):586-591
pubmed: 27364080
J Endourol. 2018 Jul;32(7):597-602
pubmed: 29737199
Urology. 2005 Feb;65(2):265-9
pubmed: 15708035
Antibiotics (Basel). 2020 Aug 01;9(8):
pubmed: 32752222
Cent European J Urol. 2019;72(4):393-397
pubmed: 32015909
J Endourol. 2017 Dec;31(12):1226-1230
pubmed: 29073769
J Endourol. 2008 May;22(5):919-22
pubmed: 18370611
Urology. 2014 Jul;84(1):42-5
pubmed: 24837456
J Endourol. 2019 Feb;33(2):71-78
pubmed: 30612446
Microorganisms. 2020 Jun 05;8(6):
pubmed: 32516902
Urolithiasis. 2014 Apr;42(2):155-8
pubmed: 24323075
Urol Clin North Am. 2019 May;46(2):303-313
pubmed: 30961862
Antibiotics (Basel). 2021 May 02;10(5):
pubmed: 34063317
Maedica (Bucur). 2021 Dec;16(4):568-573
pubmed: 35261654
World J Urol. 2017 May;35(5):809-818
pubmed: 27671898
Endosc Int Open. 2015 Aug;3(4):E259-65
pubmed: 26355428
World J Urol. 2022 Jan;40(1):251-256
pubmed: 34424373
J Endourol. 2016 Jun;30(6):655-9
pubmed: 27084572
BJU Int. 2018 May;121 Suppl 3:55-61
pubmed: 29656467
Transl Androl Urol. 2019 Sep;8(Suppl 4):S418-S425
pubmed: 31656747
Urolithiasis. 2018 Nov;46(6):587-593
pubmed: 29356873
J Clin Med. 2021 Jun 11;10(12):
pubmed: 34208267
J Endourol. 2017 Dec;31(12):1301-1306
pubmed: 28978227